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Abstract
This article, based on the 2018 European Society of
Cardiology syncope guidelines, highlights the key features of the
management of syncope in the Emergency Department (ED) based
on risk stratification. Firstly Transient Loss of Consciousness of a
syncopal nature should be established. Secondly the treating clini-
cian should ask whether syncope is the presenting feature of an
obvious acute disease; if so, treatment and management should fol-
low the guidelines of the specific complaint. If there is no obvious
underlying cause, the treating clinician should assess the risk of a
serious outcome aided by a risk stratification approach using his-
tory, past medical history, examination and ECG. Patients with
low-risk characteristics are more likely to have reflex, situational
or orthostatic syncope with generally an excellent prognosis and
should likely be able to be discharged from the ED with education.
Patients with high-risk characteristics are more likely to have car-
diac syncope requiring urgent investigation and likely admission
but alternatively may be able to be observed in an Observation or
Syncope Unit. Patients with neither high nor low-risk features can
probably be safely managed in an outpatient setting; there is evi-
dence that management in an ED observation unit and/or fast track
to a syncope clinic is beneficial. Risk stratification scores and clin-
ical decision rules are yet to prove useful. There is little evidence
that hospital admission in unexplained syncope is useful and novel
organisational approaches such as ED observation units and syn-
cope in- and outpatient units offer safe and effective alternatives to
admission.
Introduction
This article, based on the new 2018 European Society of
Cardiology Guidelines for the diagnosis and management of syn-
cope highlights the key features of the management of syncope in
the Emergency Department (ED).1
Importance of satisfactory emergency department
syncope management
This is an important topic; syncope is a common presentation
to EDs and there are problems with current management. These
include the lack of high quality evidence based strategies to detect
patients at high risk of short-term adverse events and those of long-
term adverse outcome, the high admission rate and the low inci-
dence of short-term adverse events. Challenges that can contribute
to unsatisfactory practice include the lack of specialist syncope
experts and specialist syncope clinics in many hospitals, the lack
of a clear speciality leading the field (cardiology, internal medicine
and geriatric medicine specialties are among the commonest to
lead care in most hospitals), differences in the speciality leading
care in the ED (emergency medicine is the commonest to lead care
in most EDs however in some countries where it is less developed,
internal or geriatric medicine maybe the first to see syncope
patients in the ED), differences in the time that patients are allowed
to spend in the ED before they must be admitted to a hospital bed
(ranging from 4 hours in the United Kingdom to over 24 hours in
others), differences in diagnostic pathways within and between
hospitals, and finally difficulties disseminating and teaching best
practice due to many of the above issues.
Diagnosis and definition of syncope
As discussed at the SYNERGI (SYNcope Expert Research
Group International)2 First International Workshop on Syncope
Risk Stratification in the ED in Gargnano in 2013,3 diagnosing
Transient Loss of Consciousness (T-LOC) as being of syncopal
origin (i.e. due to cerebral hypoperfusion) can be difficult in the
ED. A very careful history is needed to differentiate syncope from
epilepsy and other non-TLOC conditions such as pre-syncope,
light-headedness, vertigo, disequilibrium, mechanical and collapse
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(i.e. loss of postural tone). In the absence of witnesses this is often
very difficult. 
SYNERGI2 suggest a pragmatic definition of syncope: a tran-
sient loss of consciousness, associated with inability to maintain
the postural tone and with immediate spontaneous and complete
recovery. Syncope should be associated with at least 1 of the fol-
lowing: i) clinical features suggestive of specific forms of syncope
(e.g. vasovagal, orthostatic, cardiac, neurologic); or ii) the
absence of clinical features specific for another form of transient
loss of consciousness such as epileptic seizure, hypoglycemia, or
trauma.3
Other clinical tips here are to: i) Document all presenting
symptoms fully; ii) Get any available history from witnesses or
paramedics; iii) Examine the ambulance notes for initial observa-
tions and review any pre hospital ECG.
Another critical point is to identify and manage patients with
pre-syncope. Pre-syncope is the feeling of being about to pass out
without actual Loss of Consciousness. Pre-syncope has ordinarily
thought to be associated with a better prognosis compared with syn-
cope. However, some recent studies have suggested that patients
presenting with pre-syncope are characterized by outcomes that are
similar to those observed in patients with syncope.4-6
Is there a serious underlying diagnosis?
Normally the ED clinician can establish the presenting com-
plaint of syncope. It should be noted that depending on geograph-
ical considerations, the ED clinician might be an emergency, inter-
nal medicine, geriatric or even a neurology clinician. Regardless,
the next step is to see whether there is a serious underlying diag-
nosis or aetiology that can be identified in the ED, especially if this
condition is associated with the potential for rapid clinical deterio-
ration (e.g. abdominal aortic aneurysm, upper gastrointestinal
bleeding).7,8 Once established, subsequent management of the
patient presenting with syncope, will focus on treating the under-
lying cause using any guidelines specific to this condition. Once an
underlying diagnosis is made, syncope guidelines are not benefi-
cial. Most non-cardiovascular and some cardiovascular life-threat-
ening underlying conditions are obvious in the ED and in total
around 50% of patients have an underlying diagnosis or aetiology
that can be identified in the ED.9
What is the risk of a serious outcome?
When the cause of syncope remains uncertain after initial eval-
uation by a clinician in the ED, the next step is to assess the risk of
a serious outcome, essentially the risk of a future major cardiovas-
cular event or of sudden cardiac death, and to use this risk profile
to guide the patient’s subsequent management and disposition.10
Risk stratification is important, for two reasons. Firstly it is
important to recognise low-risk patients who are more likely to
have reflex, situational or orthostatic syncope with generally an
excellent prognosis,11 although postural syncope may be associated
with slightly higher risk poor outcome owing to the severity of
comorbidities compared with the general population.12 These low-
risk patients should be able to be discharged from the ED and most
should be able to be managed with adequate patient education and
counselling that can be started in the ED. Some patients with fre-
quent or severe (causing injury) episodes may require further
investigation (e.g. to uncover whether syncope is cardio inhibitory
versus vasodepressor) and/or specific treatment (e.g. pacemaker
insertion, commencement or withdrawal of drug treatment).
Secondly it is important to recognise patients more likely to have
cardiac syncope who will require urgent investigation. This may
require admission depending on available services, which are like-
ly to be hospital dependent. Structural heart disease13-18 and prima-
ry electrical disease19 are major risk factors for sudden cardiac
death and overall mortality in patients with syncope.
Risk stratification
The 2018 European Society of Cardiology (ESC) Guidelines
for the diagnosis and management of syncope1 recommend that ED
risk stratification should be undertaken using the following risk
stratification system using high-risk features (suggestive of a seri-
ous condition) and low-risk features (suggestive a benign condi-
tion) in patients with syncope at initial evaluation in the ED.
Syncopal event
Low risk
i) Associated with prodrome typical of reflex syncope (e.g.
light-headedness, feeling of warmth, sweating, nausea, vomiting);
ii) After sudden unexpected unpleasant sight, sound, smell, or pain;
iii) After prolonged standing or crowded, hot places; iv) During a
meal or postprandial; v) Triggered by cough, defaecation, or mic-
turition; vi) With head rotation or pressure on carotid sinus (e.g.
tumour, shaving, tight collars); vii) Standing from supine/sitting
position.
High risk (red flag)
Major: i) New onset of chest discomfort, breathlessness,
abdominal pain, or headache; ii) Syncope during exertion or when
supine; iii) Sudden onset palpitation immediately followed by syn-
cope.
Minor (high risk only if associated with structural heart disease
or abnormal Electrocardiogram; ECG): i) No warning symptoms
or short (<10 s) prodrome; ii) Family history of Sudden Cardiac
Death (SCD) at young age; iii) Syncope in the sitting position.
Past medical history
Low risk
i) Long history (years) of recurrent syncope with low-risk fea-
tures with the same characteristics of the current episode; ii)
Absence of structural heart disease.
High risk (red flag)
Major: Severe structural or coronary artery disease (heart fail-
ure, low left ventricular ejection fraction; LVEF or previous
myocardial infarction).
Physical examination
Low risk
Normal examination.
High risk (red flag)
i) Unexplained systolic blood pressure (BP) in the ED <90
mmHg; ii) Suggestion of gastrointestinal bleed on rectal examina-
tion; iii) Persistent bradycardia (<40 beats per minute; bpm) in
awake state and in absence of physical training; iv) Undiagnosed
systolic murmur.
Electrocardiography
Low risk
Normal ECG.
High risk (red flag)
Major: i) ECG changes consistent with acute ischaemia; ii)
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Mobitz II second- and third-degree atrio-ventricular (AV) block;
iii) Slow Atrial Fibrillation (AF) (<40 bpm); iv) Persistent sinus
bradycardia (<40 bpm), or repetitive sinoatrial block or sinus paus-
es >3 seconds in awake state and in absence of physical training;
v) Bundle branch block, intraventricular conduction disturbance,
ventricular hypertrophy, or Q waves consistent with ischaemic
heart disease or cardiomyopathy; vi) Sustained and non-sustained
Ventricular Tachycardia (VT); vii) Dysfunction of an implantable
cardiac device (pacemaker or implantable cardioverter defibrilla-
tor; ICD); viii) ST-segment elevation with type 1 morphology in
leads V1−V3 (Brugada pattern); ix) QTc >460 ms in repeated 12-
lead ECGs indicating long QT syndrome (LQTS).
Minor (high risk only if history consistent with arrhythmic
syncope): i) Mobitz I second-degree AV block and 1° degree AV
block with markedly prolonged PR interval; ii) Asymptomatic
inappropriate mild sinus bradycardia (40-50 bpm), or slow AF (40-
50 bpm); iii) Paroxysmal supraventricular tachycardia (SVT) or
atrial fibrillation; iv) Pre-excited QRS complex; v) Short QTc
interval (≤340 ms); vi) Atypical Brugada patterns; vii) Negative T
waves in right precordial leads, epsilon waves suggestive of
arrhythmogenic right ventricular cardiomyopathy.
Once ED risk stratification has been undertaken the ESC ED
risk stratification flowchart shown in Figure 1 should be used to
determine the subsequent patient’s management.1
Patients with low-risk features
A patient with only low-risk characteristics and without any
high-risk characteristics can be classified as low risk and can be
safely discharged from the ED. These patients do not need further
diagnostic tests in the ED and their likely diagnosis is reflex, situ-
ational, or orthostatic syncope. These patients may benefit from
reassurance, education and counselling, which the patient’s
General Practitioner can provide. They may also benefit from an
advice sheet on low-risk syncope. Low-risk patients may still
require further examination or investigation, and possibly admis-
sion to hospital in the event of them having associated injury or
social or welfare reasons meaning they are not able to be dis-
charged home.
Current use of hospitalization for patients with low-risk fea-
tures is both inefficient and inconsistent; these patients can be safe-
ly discharged home from the ED. Avoiding admission of these
patients may significantly reduce hospital admissions, thus cutting
costs and decreasing adverse outcomes associated with unneces-
sary hospitalization.
Patients with high-risk features
Patients with any high-risk features should be classified as
high risk and should not be discharged from the ED as they require
a timely and thorough diagnostic approach and may need urgent
treatment. This is likely to mean an admission to hospital unless
patients can access urgent advanced investigation such as echocar-
diography, ECG monitoring, specialized cardiovascular tests and
review from an expert in syncope during either a prolonged stay in
the ED or in a syncope clinical decision/investigation unit. These
                             Review
Figure 1. Emergency department risk stratification flowchart to determine syncope patient management of syncope. SU, syncope unit.
Reproduced from Brignole M, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. European Heart Journal
(2018) 00, 1-69, doi:10.1093/eurheartj/ehy037. Reproduced by permission of Oxford University Press on behalf of the European
Society of Cardiology. (c) European Society of Cardiology 2018. All rights reserved. This figure is not included under the Open Access
license of this Publication.
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patients should be monitored (although it is unclear for how long
this should be, most experts suggest from 4 to 24 hours) in a setting
where resuscitation can be performed in case of deterioration.20,21
The ability for patients to access an ED observation unit or
syncope clinical decision unit will be dependent on geographical
and hospital considerations. Not all countries have Emergency
Departments. In some countries, patients have to be discharged
from the ED or admitted to hospital within a certain time of their
attendance to the ED (e.g. in the UK, this period is 4 hours).
Despite them having being many advantages, many hospitals do
not currently have observation/clinical decision units. If this is the
case, until such a time when these services are available, the high-
risk syncope patient will require admission to hospital. Patients
with high-risk features should not be discharged home without fol-
low-up from the ED, as they require an intensive diagnostic
approach.
Patients with intermediate-risk features
There will be patients that have neither high nor low-risk fea-
tures. Dealing with these intermediate-risk patients is difficult.
Many will require expert syncope opinion and this can probably be
safely managed in an outpatient setting.22 There is evidence that
management in an ED observation unit and/or fast track to a syn-
cope clinic is beneficial. Shen et al.23 showed that a designated
syncope unit in the ED, where patients could stay for up to 6 hours,
significantly improved diagnostic yield in the ED, and reduced
hospital admission and total length of hospital stay without affect-
ing recurrent syncope and all-cause mortality among intermediate-
risk patients. Patients underwent continuous cardiac monitoring,
an hourly vital sign check, echocardiography (in patients with
abnormal cardiovascular examination findings or an abnormal
ECG), tilt table testing, and specialist consultation if indicated. Sun
et al.23 showed that an ED observation syncope protocol reduced
admission rates, length of hospitalization, and index hospital costs,
with no difference in the rates of safety events, quality of life, or
patient satisfaction. Patients in this study could stay for up to 24
hours in an ED observation unit, receiving continuous cardiac
monitoring for at least 12 hours, interval cardiac troponin tests,
echocardiograms for patients with a cardiac murmur on chest aus-
cultation, and additional testing at the ED clinician’s discretion.
Requirements of an emergency department syn-
cope observation unit
An ED syncope observation unit should have the following
tests, equipment, and characteristics: ECG and BP monitoring,
standing test facilities, carotid sinus massage capability, echocar-
diogram, blood tests, and availability of consultation by a syncope
expert and neurologists, cardiologists, geriatricians, and psychia-
trists where required.
Does the patient need to be admitted to hospital?
The final question that the treating clinician needs to ask is
whether the patient should be admitted to hospital. Approximately
50% of patients who present to the ED for syncope are admitted to
hospital, although the rate of admissions varies between 12% and
86% (Table 1).9,15,24-34 The adoption of clinical decision rules and
standard protocols has not changed the rate of hospital admission
significantly and many are unnecessary.35 Among the patients who
present to the ED with syncope, only 0.8% die, 6.9% have a non-
fatal severe outcome whilst in the ED, and another 3.6% have a
serious outcome in the next 7-30 days (Table 1). Therefore, where-
as it is crucial to identify these high-risk patients to ensure early,
rapid, and intensive investigation, the rate of post-ED serious out-
come is actually quite low and not all patients at high risk need to
be admitted.
Some high-risk patients may inevitably require admission to
hospital in the event of severe coexisting disease, injury caused by
                                                                                                                             Review
Table 1. Admission rate and composite estimate of short-term (7-30 days) outcomes of patients presenting in emergency department
with Transient Loss of Consciousness (T-LOC). Reproduced from Brignole M, et al. 2018 ESC Guidelines for the diagnosis and man-
agement of syncope. European Heart Journal (2018) 00, 1-69, doi:10.1093/eurheartj/ehy037. Reproduced by permission of Oxford
University Press on behalf of the European Society of Cardiology. (c) European Society of Cardiology 2018. All rights reserved. This
table is not included under the Open Access license of this Publication.
Author/year/country                           Patients      Number      7-30 day    7-30 day non-fatal     7-30 day non-fatal            7-30 day non-fatal 
                                                                 with         admitted        Death        severe outcomea         severe outcome       severe outcomea identified
                                                               T-LOC                                                                                   identified in the ED             after initial visit
Costantino, 2008, Italy25                                      676            218 (32%)        5 (0.7%)                 36 (5.3%)                                 n/a                                                n/a
Brignole, 2006, Italy26                                           465            178 (38%)        6 (1.3%)                       n/a                                       n/a                                                n/a
Reed, 2010, UK9                                                   1100           541 (49%)       17 (1.5%)                79 (7.2%)                                 n/a                                                n/a
Ungar, 2015, Italy34                                                295             92 (31%)         1 (0.3%)                       n/a                                       n/a                                          21 (7.1%)
Birnbaum, 2008, US27                                           713            613 (86%)        4 (0.6%)                 57 (8.0%)                           32 (4.5%)                                    25 (3.5%)
Grossman, 2007, US28                                          293            201 (69%)        7 (2.4%)                 68 (23%)                            56 (19%)                                    12 (4.1%)
Quinn, 2004, US29                                                 684            376 (55%)        5 (0.7%)                79 (11.5%)                                n/a                                                n/a
Quinn, 2006, US15                                                 760            448 (59%)        3 (0.4%)               108 (14.2%)                         54 (7.1%)                                    54 (7.1%)
Schladenhaufen, 2008, US30                               517            312 (60%)        5 (1.0%)                 98 (19%)                          80 (15.5%)                                   18 (3.4%)
Sun, 2007, US31                                                      477            277 (58%)             n/a                     56 (11.7%)                          40 (8.6%)                                    16 (3.4%)
Daccarett, 2011, US32                                           254            118 (46%)        1 (0.4%)                 15 (5.9%)                            8 (3.1%)                                      7 (2.8%)
Thiruganasambanda-moorthy, 2014, CAN33    505             62 (12%)         5 (1.0%)                 49 (9.7%)                           22 (4.4%)                                    27 (5.3%)
Thiruganasambanda-moorthy, 2015, CAN34   3662b          474 (13%)       31 (0.9%)              345 (10.3%)                        225 (6.7%)                                  120 (3.6%)
Median (IQR)                                                                       49% (32-59)  0.8% (0.6-1.1)      10.3% (7.6-13.0)                6.9% (4.5-10.3)                           3.6% (3.4-5.3)
aNonfatal severe outcomes generally are defined as a significant new diagnosis, a clinical deterioration, serious injury with recurrence, or a significant therapeutic intervention; b3365 patients had 30 day follow-up.
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the syncopal event, need of further urgent evaluation and treatment
(e.g. ECG monitoring, echocardiography, stress test, angiography)
if it cannot be achieved any another way (i.e. observation unit) and
if syncope related treatment is required. The implementation of
novel care pathways and organizational approaches such as ED
observation units and syncope in- and outpatient units do offer safe
and effective alternatives to admission in all other patients with
high-risk features (e.g. syncope during exertion, palpitations at the
time of syncope, suspected device malfunction or inappropriate
intervention). Integrated models comprising a short stay in the ED
under observation coupled with fast track to a syncope unit have
been shown to reduce admission rates to 29%.36 Among patients
not admitted, 20% were discharged after a short observation in the
ED, 20% were fast-tracked to the syncope unit, and 31% were dis-
charged directly from the ED.
Clinical decision rules
There are several ED syncope risk-stratification tools and
Clinical Decision Rules (CDRs) that aim to stratify patients with
syncope in the ED based on medical history, examination and ECG
findings into those with a high or low risk of developing both short
(7 and 30 day) and long term (1 year) serious outcomes.9,11,13,21,29
Currently available clinical decision rules are not used widely
in EDs, as they have not shown better sensitivity, specificity, or
prognostic yield compared with clinical judgment in predicting
short-term serious outcomes after syncope.37 They should not be
used alone to perform risk stratification in the ED.
The failure of CDRs is likely because they attempt to predict
prognosis on the basis of presenting complaint and attempt to pre-
dict multiple heterogeneous outcomes. CDRs struggle to identify
rarer treatable conditions; most CDRs would correctly predict a
worse but less modifiable 30 day outcome for an 80 year old male
with a history of cardiovascular disease and a non specific abnor-
mal ECG presenting with reflex syncope, compared to a 25 year
old female with exertional syncope caused by treatable congenital
long QT syndrome. Clinical decision rules can predict poor out-
comes, but most syncope deaths and many poor outcomes are asso-
ciated with underlying illness rather than syncope per se,38 partic-
ularly in the long term.25
Biomarkers
Although there is increasing interest in the use of biomarkers
such as troponins and brain natriuretic peptides for ED syncope
risk stratification, these cannot be recommended for routine care at
present.39-43
Whilst this article assumes that most patients will be seen in an
ED setting, it is acknowledged that some individuals with a serious
underlying diagnosis may present to General/Family Practice
where some diagnostic resources such as ECG may not be avail-
able. The guidance discussed may be used to determine the need
for urgent referral to the ED or outpatient clinic. However, patients
who attend the ED are likely to represent the more extreme end of
the syncope severity spectrum and the majority of patients (espe-
cially those of younger age) who either do not seek medical atten-
tion, or who visit their GP are more likely to have had an episode
of reflex syncope.44-47
Conclusions
The 2018 ESC syncope guidelines have introduced some
changes in ED management of patient with syncope. For the first
time, the ESC guidelines include a whole section dedicated to the
management of the patient with syncope who presents to the ED.
The guidelines advocate a risk stratification approach introducing
the concept and definitions of low and high-risk patients and low
and high-risk features. The guidelines also advocate more wide-
spread use of ED observation and syncope units, and specialist
syncope outpatient clinics to reduce admissions to hospital. The
guidelines discuss the ideal structure (staff, equipment, and proce-
dures), assessment strategies, and access and quality indicators of
such units. Finally the guidelines discuss the limited usefulness of
risk stratification and clinical decision scores.
References
1. Brignole M, Moya A, Deharo J-C, et al. 2018 ESC Guidelines
for the diagnosis and management of syncope. Eur Heart J
2018;00:1-69. 
2. SYNERGI, SYNcope Expert Research Group International.
Available from: https://twitter.com/SyncopeGroup. Accessed:
April 2018.
3. Sun BC, Costantino G, Barbic F, et al. Priorities for emergency
department syncope research. Ann Emerg Med 2014;64:649-
55.
4. Thiruganasambandamoorthy V, Stiell IG, Wells GA, et al.
Outcomes in presyncope patients: a prospective cohort study.
Ann Emerg Med 2015;65:268-76.e266.
5. Greve Y, Geier F, Popp S, et al. The prevalence and prognostic
significance of near syncope and syncope: a prospective study
of 395 cases in an emergency department (the SPEED study).
Dtsch Arztebl Int 2014;111:197-204.
6. Krahn AD, Klein GJ, Yee R, REVEAL Investigators.
Predictive value of presyncope in patients monitored for
assessment of syncope. Am Heart J 2001;141:817-21.
7. Crane SD. Risk stratification of patients with syncope in an
accident and emergency department. Emerg Med J 2002;19:
23-7.
8. Sheldon R, Rose S, Ritchie D, et al. Historical criteria that dis-
tinguish syncope from seizures. J Am Coll Cardiol
2002;40:142-8.
9. Reed MJ, Newby DE, Coull AJ, et al. The ROSE (risk stratifi-
cation of syncope in the emergency department) study. J Am
Coll Cardiol 2010;55:713-21.
10. Huff JS, Decker WW, Quinn JV, et al. American College of
Emergency Physicians. Clinical policy: critical issues in the
evaluation and management of adult patients presenting to the
emergency department with syncope. Ann Emerg Med
2007;49:431-44.
11. Soteriades ES, Evans JC, Larson MG, et al. Incidence and
prognosis of syncope. N Engl J Med 2002;347:878-85.
12. Ricci F, Fedorowski A, Radico F, et al. Cardiovascular morbid-
ity and mortality related to orthostatic hypotension: a meta-
analysis of prospective observational studies. Eur Heart J
2015;36: 1609-17.
13. Colivicchi F, Ammirati F, Melina D, OESIL (Osservatorio
Epidemiologico sulla Sincope nel Lazio) Study Investigators.
Development and prospective validation of a risk stratification
system for patients with syncope in the emergency department:
the OESIL risk score. Eur Heart J 2003;24: 811-9.
14. Del Rosso A, Ungar A, Maggi R, et al. Clinical predictors of
cardiac syncope at initial evaluation in patients referred urgent-
ly to a general hospital: the EGSYS score. Heart
2008;94:1620-6.
15. Quinn J, McDermott D, Stiell I, et al. Prospective validation of
the San Francisco Syncope Rule to predict patients with seri-
ous outcomes. Ann Emerg Med 2006;47:448-54.
16. Olshansky B, Poole JE, Johnson G, SCD-HeFT Investigators.
                             Review
No
n-c
om
me
rci
al 
us
 on
ly
                                    [Emergency Care Journal 2018; 14:7430]                                                        [page 9]
Syncope predicts the outcome of cardiomyopathy patients:
analysis of the SCD-HeFT study. J Am Coll Cardiol
2008;51:1277-82.
17. Sarasin FP, Hanusa BH, Perneger T, et al. A risk score to pre-
dict arrhythmias in patients with unexplained syncope. Acad
Emerg Med 2003;10:1312-7.
18. Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA.
Syncope in advanced heart failure: high risk of sudden death
regardless of origin of syncope. J Am Coll Cardiol
1993;21:110-6.
19. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015
ESC Guidelines for the management of patients with ventricu-
lar arrhythmias and the prevention of sudden cardiac death: the
task force for the management of patients with ventricular
arrhythmias and the prevention of sudden cardiac death of the
European Society of Cardiology (ESC). Endorsed by:
Association for European Paediatric and Congenital
Cardiology (AEPC). Eur Heart J 2015;36:2793-867.
20. Casagranda I, Brignole M, Cencetti S, et al. Management of
transient loss of consciousness of suspected syncopal cause,
after the initial evaluation in the Emergency Department.
Emerg Care J 2016;12:25-7.
21. Costantino G, Sun BC, Barbic F, et al. Syncope clinical man-
agement in the emergency department: a consensus from the
first international workshop on syncope risk stratification in
the emergency department. Eur Heart J 2016;37:1493-8.
22. Kenny RA, Brignole M, Dan GA, et al. Syncope Unit: ratio-
nale and requirement-the European Heart Rhythm Association
position statement endorsed by the Heart Rhythm Society.
Europace 2015;17:1325-40.
23. Shen WK, Decker WW, Smars PA, et al. Syncope Evaluation
in the Emergency Department Study (SEEDS): a multidisci-
plinary approach to syncope management. Circulation
2004;110:3636-45.
24. Sun BC, McCreath H, Liang LJ, et al. Randomized clinical
trial of an emergency department observation syncope protocol
versus routine inpatient admission. Ann Emerg Med
2014;64:167-75.
25. Costantino G, Perego F, Dipaola F, et al. Short- and long-term
prognosis of syncope, risk factors, and role of hospital admis-
sion: results from the STePS (Short-Term Prognosis of
Syncope) study. J Am Coll Cardiol 2008;51:276-83.
26. Brignole M, Menozzi C, Bartoletti A, et al. A new management
of syncope: prospective systematic guideline-based evaluation
of patients referred urgently to general hospitals. Eur Heart J
2006; 27:76-82.
27. Birnbaum A, Esses D, Bijur P, et al. Failure to validate the San
Francisco Syncope Rule in an independent emergencydepart-
ment population. Ann Emerg Med 2008;52:151-9.
28. Grossman SA, Fischer C, Lipsitz LA, et al. Predicting adverse
outcomes insyncope. J Emerg Med 2007;33:233-9.
29. Quinn JV, Stiell IG, McDermott DA, et al. Derivation of the
San Francisco Syncope Rule to predict patients withshort-term
serious outcomes. Ann Emerg Med 2004;43:224-32.
30. Schladenhaufen R, Feilinger S, Pollack M, et al. Application of
San Francisco Syncope Rule in elderly ED patients. Am J
Emerg Med 2008;26:773-8.
31. Sun BC, Mangione CM, Merchant G, et al. External validation
of the San Francisco Syncope Rule. Ann Emerg Med
2007;49:420-7.e1-4.
32. Daccarett M, Jetter TL, Wasmund SL, et al. Syncope in the
emergency department: comparison of standardized admission
criteria with clinical practice. Europace 2011;13:1632-8.
33. Thiruganasambandamoorthy V, Hess EP, Turko E, et al.
Outcomes in Canadian Emergency Department Syncope
Patients – are we doing a good job? J Emerg Med
2013;44:321-8.
34. Thiruganasambandamoorthy V, Steill IG, Sivilotti ML, et al.
Emergency department management of syncope: need for stan-
dardization and improved risk stratification. Intern Emerg Med
2015;10:619-27.
35. Sheldon RS, Morillo CA, Krahn AD, et al. Standardized
approaches to the investigation of syncope: Canadian
Cardiovascular Society position paper. Can J Cardiol
2011;27:246-53.
36. Ungar A, Tesi F, Chisciotti VM, et al. Assessment of a struc-
tured management pathway for patients referred to the
Emergency Department for syncope: results in a tertiary hospi-
tal. Europace 2016;18:457-62.
37. Costantino G, Casazza G, Reed M, et al. Syncope risk stratifi-
cation tools vs clinical judgment: an individual patient data
meta-analysis. Am J Med 2014;127: 1126.e1113-1125.
38. Kapoor WN, Peterson J, Wieand HS, Karpf M. Diagnostic and
prognostic implications of recurrences in patients with syn-
cope. Am J Med 1987;83:700-8.
39. Costantino G, Solbiati M, Casazza G, et al. Usefulness of N-
terminal pro-B-type natriuretic Peptide increase as a marker
for cardiac arrhythmia in patients with syncope. Am J Cardiol
2014;113:98-102.
40. Reed MJ, Mills NL, Weir CJ. Sensitive troponin assay predicts
outcome in syncope. Emerg Med J 2012;29:1001-3.
41. Thiruganasambandamoorthy V, Ramaekers R, Rahman MO, et
al. Prognostic value of cardiac biomarkers in the risk-stratifi-
cation of syncope: a systematic review. Int Emerg Med 2015
[Ahead of print]. doi: 10.1007/s11739-015-1318-1.
42. Fedorowski A, Burri P, Struck J, et al. Novel cardiovascular
biomarkers in unexplained syncopal attacks: the SYSTEMA
cohort. J Intern Med 2013;273: 359-67.
43. Reed MJ, Newby DE, Coull AJ, et al. Role of brain natriuretic
peptide (BNP) in risk stratification of adult syncope. Emerg
Med J 2007;24:769-73.
44. Soteriades ES, Evans JC, Larson MG, et al. Incidence and
prognosis of syncope. N Engl J Med 2002;347:878-85.
45. Serletis A, Rose S, Sheldon AG, Sheldon RS. Vasovagal syn-
cope in medical students and their first-degree relatives. Eur
Heart J 2006;27:1965-70.
46. Colman N, Nahm K, Ganzeboom KS, et al. Epidemiology of
reflex syncope. Clin Auton Res 2004;14 Suppl 1:i9-i17.
47. Ganzeboom KS, Mairuhu G, Reitsma J, et al. Lifetime cumu-
lative incidence of syncope in the general population: a study
of 549 Dutch subjects aged 35-60 years. J Cardiovasc
Electrophysiol 2006;17:1172-6.
                                                                                                                             Review
No
n-c
om
m
rci
al 
us
e o
nly
